Novo Nordisk’s obesity drug CagriSema falls short against Eli Lilly’s in trial

Novo Nordisk’s obesity drug CagriSema falls short against Eli Lilly’s in trialSource: Reuters
أخبار الاستثمار والأسواق المالية من موقع Investing.com

Novo Nordisk’s obesity drug CagriSema falls short against Eli Lilly’s in trialSource: Reuters
Novo Nordisk shares plunge after obesity drug falls short of rival in trialSource: Investing.com

Johnson Matthey shares sink 15% as Honeywell trims deal to £1.33 blnSource: Investing.com

Ahold Delhaize downgraded to accumulate by KBC SecuritiesSource: Investing.com

US ambassador urges Portugal to buy F-35s, join top-tier air forcesSource: Reuters

JD Sports shares surge on £200m buyback programmeSource: Investing.com
Is UK housing set for policy-driven upside? Barclays maintains top picksSource: Investing.com

Daloz becomes chairman and CEO of Dassault SystèmesSource: Investing.com

Lazio stock drops after club dismisses Qatari takeover interestSource: Investing.com

Smiths News warned by UK pensions regulator over Tuffnells schemeSource: Investing.com